Tag Archives: Vertex

Fosamprenavir – opposition – india

Indian patent journal of this week (Sep 16th, 2011) has a post grant opposition filed under section 25(2). Lupin has filed post grant opposition to 240930 (2210/Cal/1998) under section 25(2)  on June 08, 2011. The ‘930 patent seems to cover Fosamprenavir, is … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , , , , | Leave a comment

CI & Patent News: 23/11/2010a

1) Vertex Completes New Drug Application for Telaprevir for Hepatitis C (Link) 2) Gilead Sciences Submits New Drug Application to U.S. FDA for Once-Daily Single-Tablet Regimen of Truvada® (emtricitabine and tenofovir disoproxil fumarate)and TMC278 (rilpivirine hydrochloride) for HIV (Link) 3) Wockhardt Ltd. has … Continue reading

Posted in Daily interesting IP news | Tagged , , , | Leave a comment